BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17514588)

  • 1. Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice.
    Zelinka T; Eisenhofer G; Pacak K
    Stress; 2007 Jun; 10(2):195-203. PubMed ID: 17514588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma: a review.
    Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
    Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
    Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytomas and secreting paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How many pathways to pheochromocytoma?
    Neumann HP; Hoegerle S; Manz T; Brenner K; Iliopoulos O
    Semin Nephrol; 2002 Mar; 22(2):89-99. PubMed ID: 11891502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phaeochromocytoma: a catecholamine and oxidative stress disorder.
    Pacak K
    Endocr Regul; 2011 Apr; 45(2):65-90. PubMed ID: 21615192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The sympathetic system and neuroendocrine hypertension].
    Zuccala' A; Di Nicolo' P; Fiorenza S; Lifrieri F; Rapana' R
    G Ital Nefrol; 2008; 25(2):203-14. PubMed ID: 18350500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
    Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Personal experience in diagnosis and localization of pheochromocytoma].
    Andjelković Z; Tavcar I
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():14-9. PubMed ID: 12584992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endocrine aspects of diagnosis and therapy of pheochromocytoma].
    Kendereski A; Micić D
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():1-6. PubMed ID: 12584990
    [No Abstract]   [Full Text] [Related]  

  • 14. Functioning thoracic paraganglioma: association with Von Hippel-Lindau syndrome.
    Bender BU; Altehöfer C; Januszewicz A; Gärtner R; Schmidt H; Hoffmann MM; Heidemann PH; Neumann HP
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3356-60. PubMed ID: 9329368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and therapeutic procedures in pheochromocytoma: current trends].
    Widimský J; Zelinka T; Petrák O; Strauch B; Safarík L; Kasalický M; Vranková A; Holaj R
    Vnitr Lek; 2007 Apr; 53(4):428-33. PubMed ID: 17578179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phaeochromocytoma.
    Lenders JW; Eisenhofer G; Mannelli M; Pacak K
    Lancet; 2005 Aug 20-26; 366(9486):665-75. PubMed ID: 16112304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current opinion in pathogenesis of pheochromocytoma].
    Mazurkiewicz M; Wasiutyński A
    Pol Merkur Lekarski; 2007 Jun; 22(132):509-13. PubMed ID: 17874618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):421-34. PubMed ID: 16980203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.